First-in-man Single-dose and Multiple Dose Study to Evaluate the Safety, Tolerability and Efficacy ofHY-133

Conditions: Staphylococcus Aureus Interventions: Drug: HY_133; Drug: Placebo Sponsors: University Hospital Tuebingen Not yet recruiting

Source: ClinicalTrials.gov - March 4, 2024 Category: Research Source Type: clinical trials